📣 ESMO members: download our new book Gynaecological Tumours: Essentials for Clinicians. Editors: Christina Fotopoulou, Antonio González-Martín and Marcia Hall Download now: 🔗ow.ly/z2oa50SlGsG #ESMObooks #cervicalcancer #endometrialcancer #GynCSM

For those who prefer to apply via jobs.ac.uk Here is a link to this postdoctoral job. Apply today. (or before the deadline of Aug 10th) jobs.ac.uk/job/DIJ489/res…

Beyond excited to share our first genomics preprint led by the amazing jenna robinson and Gem Flint. We have demonstrated that G4-structures contribute to epigenetically induced chemo-resistance in ovarian cancer. See thread below for more info! biorxiv.org/content/10.110…

British Gynaecological Cancer Society (BGCS) ovarian, tubal and primary peritoneal cancer guidelines: Recommendations for practice update 2024 - European Journal of Obstetrics and Gynecology and Reproductive Biology ejog.org/article/S0301-…

Great to be at BGCS Conference this week chatting about all things National Ovarian Cancer Audit ovarian cancer audit data and quality improvement to improve survival rates across the UK. All info on ovarian.org.uk/qi .

Well done Zhao, Darren and the McNeish!! Fantastic study!!

OCA Research Centre researchers presenting their exciting research at Rivkin Ovarian Cancer Research Symposium! #OCRS2024 Surgery and Cancer Fotopoulou/Cunnea Ovarian Cancer Research group Anke Nijhuis Gaia Giannone Team McNeish Lab

Menopause or something more? Ovarian cancer symptoms - like bloating, tummy pain, and tiredness - can be confused with menopause, especially as ovarian cancer often develops around the time of menopause. Sadly, this overlap means that too many women are diagnosed late.

If something feels off with your body, talk to your doctor as soon as possible.​ ​ You might also experience: ​ → Back pain ​ → Changes in bowel habits ​ → Unexplained weight loss ​ → Post-menopausal vaginal bleeding ​ → Extreme tiredness

Massive congratulations to our wonderful Clinical Research Fellow Jennifer Ploski passing her PhD viva today! Thanks so much to Donal Brennan for examining! Well done Jennifer 🎉🎉

Our next webinar New approaches to ovarian cancer treatment will take place on Tuesday 26 November at 12.30pm. Register here to attend: eventbrite.co.uk/e/106723591434…

Research Technician post available in our research group in Imperial College to work on 3D models in ovarian cancer! Closing date for applications 9th December! Check out the job description in the advert. imperial.ac.uk/jobs/search-jo…

sciencedirect.com/science/articl… Great to see our paper from UKCTOCS in EBioMedicine today. The window period for detection of ovary cancer early stage disease (pre clinical detectable phase) is only ~12months. The invivo tumour doubling time is ~2.9 months.

Some fantastic speakers!! Register for the Annual meeting in London 👉bgcs.org.uk/event/asm-lond… Stephen Dobbs Mario M. Leitao, Jr David.Cibula Fotopoulou/Cunnea Ovarian Cancer Research group

Do you know what increases ovarian cancer risk? 🔹 Age 🔹 Family history 🔹 BRCA1/2 or other mutations 🔹 Jewish Eastern European ancestry 🔹 HRT use 🔹 Endometriosis 🔹 Never pregnant Many have no risk—so learning the symptoms is key. World Ovarian Cancer Day & WOCCoalition #OvarianCancer

Today is World Ovarian Cancer Day. If nothing is done to change the status quo, 8 million lives will be lost to ovarian cancer by the year 2050, the World Ovarian Cancer Coalition reports. Too many cases of this cancer are missed in the early stages, when they would be easier

Today is #WorldOvarianCancerDay. Let’s raise awareness, recognize the symptoms, and support those affected.

Ready for super-G4s? We identified clusters of G4s in intergenic regions that act as super-enhancers in ovarian cancer cells. These are de novo super-enhancers that are not underpinned by canonical epigenetic marks, supporting the epigenetic role of G4s rdcu.be/evXtf

Fantastic study Marco, congratulations! Di Antonio Research Group Ovarian Cancer Action Surgery and Cancer Imperial College London

Day 2 of the #DISARM kick-off in Athens! 🏛️ We open with a keynote from Prof. Antonis Antoniou (University of Cambridge) on the CanRisk tool. Today’s agenda: risk assessment in clinical studies, citizen awareness, strategies for adapting PRS to national populations and more!